Joshua C. Eloge, MD

Rush University Medical Center, Chicago, Illinois

  • 2Articles
  • 4.5KReads
  • 2023–2025Active
  • 6Collaborators
  • 1Citations

About

Joshua C. Eloge, MD is affiliated with Rush University Medical Center, Chicago, Illinois. Joshua C. Eloge has authored or co-authored 2 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2023 and 2025. Their work focuses on Depression (MDD).

Publications

JCP
Esketamine Augmented With Dextromethorphan/Bupropion for Treatment Resistant Depression: A Case Series
Case Series

Esketamine Augmented With Dextromethorphan/Bupropion for Treatment Resistant Depression: A Case Series

November 3, 2025

Three patients with TRD who had no or partial response to esketamine monotherapy as part of a clinical trial received augmentation with dextromethorphan/bupropion 45 mg/105 mg daily.
, , , et al
JCP
Safety and Tolerability of Concomitant Intranasal Esketamine and MAOI Treatment
Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine and MAOI Treatment

February 1, 2023

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in some patients.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe